News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Biotech and pharmaceutical companies will now have exclusive access to NexMR’s photo-induced NMR through CrystalsFirst, benefiting from the synergy of two advanced platforms working in tandem.v
Biotech and pharmaceutical companies will now have exclusive access to NexMR’s photo-induced NMR through CrystalsFirst, benefiting from the synergy of two advanced platforms working in tandem. (Image: unsplash/D koi)

NexMR joins forces with CrystalsFirst

CrystalsFirst GmbH, a leader in high-performance structural biology services, and NexMR AG, a pioneer in ultrafast NMR screening, today announced an exclusive partnership to accelerate ...

Read more …
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)

CrystalsFirst Scales Operations...

CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...

Read more …
Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)
Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)

Cooperation for faster drug discovery

The mutual project “LigandML” receives funding by the IFB Hamburg aiming to leverage experimental capabilities for better data quality paired ...

Read more …